We are live on ! Find out more
SLG

Stanley-Laman Group Portfolio holdings

AUM $814M
1-Year Est. Return 40.24%
This Fund
S&P 500
This Quarter Est. Return
-3.36%
1 Year Est. Return
+40.24%
3 Year Est. Return
+82.87%
5 Year Est. Return
+77.64%
10 Year Est. Return
+275.61%
AUM
$515M
AUM Growth
-$30.1M
Cap. Flow
-$7.12M
Cap. Flow %
-1.38%
Top 10 Hldgs %
16.03%
Holding
304
New
12
Increased
100
Reduced
100
Closed
22

Top Buys

Rank Stock Value
1
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
+$1.65M
2
ETN icon
Eaton
ETN
+$645K
3
OII icon
Oceaneering
OII
+$550K
4
CTSH icon
Cognizant
CTSH
+$485K
5
BPL
Buckeye Partners, L.P.
BPL
+$414K

Top Sells

Rank Stock Value
1
TCOM icon
Trip.com Group
TCOM
+$1.19M
2
AME icon
Ametek
AME
+$1.17M
3
AMX icon
America Movil
AMX
+$674K
4
JPM icon
JPMorgan Chase
JPM
+$542K
5
C icon
Citigroup
C
+$501K

Sector Composition

Rank Sector Weight
1 Technology 21.45%
2 Industrials 17.09%
3 Financials 8.7%
4 Healthcare 8.6%
5 Energy 8.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CLRO icon
226
ClearOne Inc
CLRO
$19.7M
$364K 0.07%
2,872
-141
-5% -$19.8K
RUTH
227
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
$346K 0.07%
31,374
-10,166
-24% -$116K
IBN icon
228
ICICI Bank
IBN
$107B
$340K 0.07%
38,049
-2,503
-6% -$23.4K
NTRS icon
229
Northern Trust
NTRS
$33.8B
$340K 0.07%
5,000
– –
CVD
230
DELISTED
COVANCE INC.
CVD
$340K 0.07%
4,325
– –
RGP
231
DELISTED
REGENCY ENERGY PARTNERS LP COMMON UTS REP LIMITED PART INTS
RGP
$333K 0.06%
10,200
– –
RTX icon
232
RTX Corp
RTX
$262B
$331K 0.06%
4,985
– –
C icon
233
Citigroup
C
$216B
$316K 0.06%
6,090
-9,962
-62% -$501K
ABB
234
DELISTED
ABB Ltd
ABB
$314K 0.06%
14,000
-1,022
-7% -$23.4K
RAVN
235
DELISTED
Raven Industries Inc
RAVN
$311K 0.06%
12,761
-4,324
-25% -$123K
CX icon
236
Cemex
CX
$18B
$310K 0.06%
26,766
– –
ORCL icon
237
Oracle
ORCL
$350B
$310K 0.06%
8,090
– –
NRP icon
238
Natural Resource Partners
NRP
$1.27B
$308K 0.06%
2,360
– –
AGU
239
DELISTED
Agrium
AGU
$307K 0.06%
3,455
+1,219
+55% +$112K
CERN
240
DELISTED
Cerner Corp
CERN
$305K 0.06%
5,122
-291
-5% -$16.4K
WNC icon
241
Wabash National
WNC
$540M
$285K 0.06%
21,374
-7,622
-26% -$105K
GPX
242
DELISTED
GP Strategies Corp.
GPX
$285K 0.06%
9,930
-4,296
-30% -$111K
AXP icon
243
American Express
AXP
$240B
$283K 0.06%
3,230
– –
AE
244
DELISTED
Adams Resources & Energy Inc
AE
$283K 0.06%
6,400
-1,852
-22% -$122K
RMCF icon
245
Rocky Mountain Chocolate Factory
RMCF
$8.65M
$282K 0.05%
22,473
– –
EPM icon
246
Evolution Petroleum
EPM
$138M
$281K 0.05%
30,606
-9,642
-24% -$99.6K
D icon
247
Dominion Energy
D
$61.9B
$276K 0.05%
4,000
– –
MFC icon
248
Manulife Financial
MFC
$70.6B
$270K 0.05%
14,028
– –
FSLR icon
249
First Solar
FSLR
$22.1B
$263K 0.05%
4,000
– –
MHG
250
DELISTED
Marine Harvest ASA
MHG
$262K 0.05%
+18,624
New +$255K
8 9
10
11 12

Similar funds

VFG
Victory Financial Group Austin, Texas $814M AUM 18.17% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
CICI
Capital Investment Counsel Inc Raleigh, North Carolina $816M AUM 34.73% 1-Year Est. Return
TFM
TFC Financial Management Boston, Massachusetts $812M AUM 17.34% 1-Year Est. Return
UAG
United Advisor Group Cincinnati, Ohio $811M AUM 18.32% 1-Year Est. Return
PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
BC
Brio Consultants San Francisco, California $818M AUM 13.48% 1-Year Est. Return

Stanley-Laman Group's Q3 2014 Portfolio in Review

As of Q3 2014, Stanley-Laman Group held 304 positions worth $515M, down 5.5% from $545M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Stanley-Laman Group's Q3 2014 filing shows 12 new, 100 increased, 100 reduced and 22 closed positions. Its largest new stake was Eagle Pharmaceuticals, Inc.: 132,790 shares worth $1.68M. The largest sale was Trip.com Group, an estimated $1.19M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Industrials and Financials.

  • Stanley-Laman Group's largest Q3 2014 buy was Eagle Pharmaceuticals, Inc.: 132,790 shares worth $1.68M.
  • Stanley-Laman Group added most to Eaton in Q3 2014, an estimated $645K increase.
  • Stanley-Laman Group's biggest Q3 2014 reduction was Trip.com Group, cutting an estimated $1.19M.
  • Stanley-Laman Group fully exited Ametek in Q3 2014, selling an estimated $1.17M.
  • Stanley-Laman Group's ten largest holdings make up 16% of its $515M portfolio in Q3 2014.
  • Stanley-Laman Group opened 12 new positions and closed 22 in Q3 2014.
  • Stanley-Laman Group's portfolio value fell 5.5% quarter-over-quarter to $515M.

Based on Stanley-Laman Group's 13F filing for Q3 2014, filed 14 Nov 2014.